Loading clinical trials...
Loading clinical trials...
Viral Excretion and Its Influencing Factors Among COVID-19 Omicron Recurrence Patients
The study analyzes the viral nucleic acid excretion and its influencing factors of SARS-COV-2 Omicron recurrence patients.
Age
All ages
Sex
ALL
Healthy Volunteers
No
Renji Hospital
Shanghai, China
Start Date
July 1, 2022
Primary Completion Date
July 1, 2023
Completion Date
August 1, 2023
Last Updated
July 22, 2022
35
ESTIMATED participants
COVID-19 Omicron Recurrence
OTHER
Lead Sponsor
RenJi Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions